
Rabelast D 30mg/20mg Capsule SR
Marketer
Shankus Acme Pharma Pvt Ltd
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Rabelast D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with the combination medication, Rabelast D 30mg/20mg Sustained-Release Capsules. This medication alleviates acidity symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion, thereby reducing discomfort. Rabelast D should be taken on an empty stomach, following your doctor's prescribed dosage and duration. Treatment length depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and potential worsening. Always inform your physician of all other medications you are using, as interactions are possible. Common, usually transient, side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately to your doctor. Drowsiness and dizziness are possible; avoid driving or activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle changes, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can complement treatment. Prior to commencing treatment, inform your doctor of any liver or kidney conditions, pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Rabelast D 30mg/20mg Capsule SR
No text provided to rephrase.
Uses of Rabelast D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rabelast D 30mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire capsule without chewing, crushing, or fracturing it. Rabelast D 30mg/20mg Sustained-Release Capsules should be administered on an empty stomach.
Common Side effects of Rabelast D 30mg/20mg Capsule SR:
- Pharyngitis
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Insomnia (difficulty in sleeping)
- Nausea
- Constipation
- Flatulence
- Nasal congestion (stuffy nose)
- Fundic gland polyps
- Back pain
How to use Rabelast D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Rabelast D 30mg/20mg Sustained-Release Capsules on an empty stomach.
How Rabelast D 30mg/20mg Capsule SR works:
Rabelast D SR capsules (30mg/20mg Domperidone/Rabeprazole) combine a prokinetic agent, Domperidone, with a proton pump inhibitor (PPI), Rabeprazole. Domperidone enhances upper gastrointestinal motility, facilitating efficient food passage. Rabeprazole decreases stomach acid production, providing relief from acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabelast D 30mg/20mg SR capsules concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Rabelast D 30mg/20mg sustained-release capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The prolonged-release Rabelast D 30mg/20mg capsule is likely not suitable for use while breastfeeding. Available human evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Rabelast D 30mg/20mg sustained-release capsules may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Rabelast D 30mg/20mg sustained-release capsules. Dosage modification of Rabelast D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Rabelast D 30mg/20mg SR capsules cautiously, potentially requiring dosage modification. Consult a physician before use. Rabelast D 30mg/20mg SR capsules are contraindicated for those with moderate to severe hepatic dysfunction.
What if you forget to take Rabelast D 30mg/20mg Capsule SR :
Should you forget a Rabelast D 30mg/20mg SR Capsule, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabelast D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
